odontogenic tumors C D A J O U R N A L , V O L 5 0 , Nº 3
C.E. Credit
A Mandibular Adenomatoid Odontogenic Tumor With a Novel Treatment Utilizing Platelet-Rich Fibrin Tarun Mundluru, DDS, MSc; David Pilgrim, DDS; Reyes Enciso, PhD; Parish P. Sedghizadeh, DDS, MS; and Mohammad A. Khalifeh, DDS, MS
abstract Background: Adenomatoid odontogenic tumor (AOT) is an uncommon odontogenic tumor that originates from odontogenic epithelium. It is predominantly found in young women, particularly in the maxilla in association with an unerupted permanent tooth. Case description: This is a case report of an AOT in a 60-year-old male with an asymptomatic mandibular lesion that radiographically presented as a mixed lesion. Conclusions: Enucleation was performed and the defect was treated with bone grafting and platelet-rich fibrin with no recurrence at follow-up. Keywords: Adenomatoid odontogenic tumor, platelet-rich fibrin, bone graft, mandibular lesion
AUTHORS Tarun Mundluru, DDS, MSc, is a graduate of the orofacial pain and oral medicine advanced specialty program at the Herman Ostrow School of Dentistry of USC. He practices in Pecos, Texas. Conflict of Interest Disclosure: None reported. David Pilgrim, DDS, is a graduate of the advanced graduate program, Master of Science program in orofacial pain and oral medicine at the Herman
Ostrow School of Dentistry of USC. He is a dental surgeon in Barbados. Conflict of Interest Disclosure: None reported. Reyes Enciso, PhD, is an associate professor in the department of geriatrics, special needs and behavioral sciences at the Herman Ostrow School of Dentistry of USC. Conflict of Interest Disclosure: None reported.
Parish P. Sedghizadeh, DDS, MS, is an associate professor in the clinical dentistry division of periodontology, diagnostic sciences and dental hygiene at the Herman Ostrow School of Dentistry of USC. Conflict of Interest Disclosure: None reported.
Mohammad A. Khalifeh, DDS, MS, is an adjunct instructor of clinical dentistry in the division of periodontology, diagnostic sciences and dental hygiene at the Herman Ostrow School of Dentistry of USC. Conflict of Interest Disclosure: None reported.
T
he adenomatoid odontogenic tumor (AOT) has been categorized by the World Health Organization (WHO) as a benign odontogenic tumor of epithelial origin even though there is admission that this lesion has always been difficult to classify.1 The nomenclature of this lesion has changed several times over its history, and the term AOT was accepted by the WHO in 1971. This tumor has also been dubbed the “tumor of two-thirds,” because about two-thirds of the cases occur in females, two-thirds of the cases occur in the second to third decade of life, two-thirds of the cases M ARC H 2 0 2 2
159
